Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in ...
Samson Mutua, a community health promoter, during the interview at Riruta Health Center on February 26, 2026. Mutua became ...
Lenacapavir, a new long-acting injectable HIV prevention drug is designed to be taken once every six months, a significant shift from the daily oral regimen that many users have struggled to maintain.
Kenya takes a massive leap in HIV prevention, here is everything you need to know about the Lenacapavir rollout.
Zimbabwe is one of the world’s first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year ...
First-in-human data for long-acting formulations of VH184, the first third-generation integrase inhibitor, and early data for capsid inhibitor VH499 to be presented, highlighting progress in ViiV's ...
Cuts to the program stem from billing errors and problems within the Health Department’s rebate claims process.
At 33, retired Constitutional Court justice Edwin Cameron thought he had, maybe, seven years left. His story traces the arc from certain death from Aids to a chronic, manageable condition at 73 — and ...
Add Yahoo as a preferred source to see more of our stories on Google. Health Canada has approved the OraQuick HIV self-test, making it the country's first oral self-test for the virus that causes AIDS ...
People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's approval of an oral self-test. U.S.-based OraSure Technologies said Tuesday its OraQuick HIV self-test ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. Sean Rourke, a Toronto-based clinical neuropsychologist and scientist at St. Michael's Hospital, holds up the box of new oral ...
TORONTO - An oral, at-home HIV test that delivers results in as little as 20 minutes and has been used in the U.S. for well over a decade is finally coming to Canada. OraSure Technologies announced ...